In the case of SLE, multiple mechanisms are involved, including an up-regulated NLRP3, caspase-1, and IL-1β in monocytes, enhancing Th17 cell polarization and activating necroptosis, events that improve disease activity. The gene discussed is IL1B; the disease is systemic lupus erythematosus.